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Abstract
Background: Unicameral (or simple) bone cysts (UBC) are benign tumours most often located in long bones of
children and adolescents. Pathological fractures are common, and due to high recurrence rates, these lesions
remain a challenge to treat. Numerous surgical procedures have been proposed, but there is no general consensus
of the ideal treatment. The aim of this investigation therefore was to study the long-term outcome after surgical
treatment in UBC.
Methods: A retrospective analysis of 46 patients surgically treated for UBC was performed for short and mid-term
outcome. Clinical and radiological outcome parameters were studied according to a modified Neer classification
system. Long-term clinical information was retrieved via a questionnaire at a minimum follow-up of 10 years after
surgery.
Results: Forty-six patients (17 female, 29 male) with a mean age of 10.0 ± 4.8 years and with histopathologically
confirmed diagnosis of UBC were included. Pathological fractures were observed in 21 cases (46%). All patients
underwent surgery for UBC (35 patients underwent curettage and bone grafting as a primary therapy, 4 curettage
alone, 3 received corticoid instillation and 4 decompression by cannulated screws). Overall recurrence rate after the
first surgical treatment was 39% (18/46), second (17.4% of all patients) and third recurrence (4.3%) were frequently
observed and were addressed by revision surgery. Recurrence was significantly higher in young and in male
patients as well as in active cysts. After a mean of 52 months, 40 out of 46 cysts were considered healed.
Prognosis was significantly better when recurrence was observed later than 30 months after therapy. After a mean
follow-up of 15.5 ± 6.2 years, 40 patients acknowledged clinically excellent results, while five reported mild and
casual pain. Only one patient reported a mild limitation of range of motion.
Conclusions: Our results suggest satisfactory overall long-term outcome for the surgical treatment of UBC,
although short-and mid-term observation show a considerable rate of recurrence independent of the surgical
technique.
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Introduction
Simple bone cysts (SBC) or unicameral bone cysts
(UBC) are benign, fluid-filled cavities most often located
in the metaphyses of long bones in children and adoles-
cents, predominantly in the proximal humerus and
f e m u r .T h ea b s o l u t ei n c i d e n c ei su n k n o w n ,b u tt h er a t e
among all bone lesions is about 3%, with a male to
female ratio of 2:1 [1,2]. Most UBC are detected
between the age of nine and fifteen [1,3]. Despite their
first recognition by Virchow in 1876 [4], the etiology of
UBC remains unknown.
There have been several theories on the pathogenesis
of these lesions, ranging from an early conviction of
inflammation and dysplastic processes as the main cause
for UBC development [5], towards theories that propa-
gate traumatic causes [6,7]. Others theorize that an
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cystic formation [8-10]. This elevation of intracavitary
pressure may be the cause of high levels of PGE-2, IL-
1b and several enzymes detected in UBC fluid [11,12].
These soluble factors may be the trigger for increased
osteoblastic activity and resulting osteolysis [13,14].
The plain radiograph aspects of a lesion concentrically
located in the medullary cavity of the metaphysis of a
long bone with expansion in all directions [15] is vir-
tually diagnostic of UBC and may be facilitated by the
so-called fallen leaf-sign, representing a fragment of cor-
tex in the cyst cavity, if present [16,17]. Further diagnos-
tic measures, such as MRI, CT scan or Tc
99 bone scan
help to differentiate these lesions from other bone
tumours, especially when cysts are not located in long
bones [18].
With skeletal maturity, asymptomatic UBC may spon-
taneously resolve [19]. However, when they are not dis-
covered incidentally, UBC may often be revealed by
pathologic fractures due to cortical destabilization. Heal-
ing of bone cysts after pathological fracture occurs
rarely [20], and immobilisation and observation may
lead to recurrent fractures in 62 to 82% [2,8,9]. There-
fore, in most cases, surgical treatment is essential for
therapeutic success.
Possible options for surgery include percutaneous
decompression with cannulated screws or pins [21,22],
percutaneous aspiration with injection of corticosteroids
or injection of bone marrow [23-26], curettage with or
without bone grafting, intramedullary nailing [27] or
combinations of the above [28,29].
Attempts have been made to define factors that might
promote recurrence. Young age and male sex may be
associated with higher recurrence rates [30-32]. Active
cysts, defined as being in direct contact to the adjacent
growth plate [33], are also reported to have a higher
recurrence rate than inactive (or latent) ones [6].
Due to their high recurrence rates and despite the
many therapies that have been proposed, UBC remain a
challenge to treat. However, clinical experience suggests
that only a few adults present to orthopaedic surgeons
with symptoms after UBC therapy.
The aim of this study was therefore to determine the
mid-term radiographic healing after surgical treatment
of unicameral bone cysts. Furthermore, we wanted to
provide long-term clinical information on a collective
treated in our institution for UBC.
Material and methods
Patients
We performed a retrospective analysis of patients trea-
ted for UBC in our institution between 1983 and 1996
via a tumour database. Patients treated after 1996 were
excluded from the study to obtain a minimum follow-up
of 10 years. In 2007, patients included in the analysis
were systematically interviewed for clinical outcome (see
below). Retrieval of patient information was approved by
the Ethics committee of the medical faculty at the Uni-
versity of Heidelberg, Germany by the number 278/99.
All patients approved the application of their data to
this study. The research reported in the paper was
undertaken in compliance with the Helsinki Declaration.
Inclusion criteria
Inclusion criteria were: 1) A unicameral bone cyst diag-
nosed by radiological, histological and operative features.
2) At least one surgical treatment in our institution with
one of the procedures listed below. 3) Retrieval of long-
term clinical information in the year 2007.
Exclusion criteria
Sixty-two patients met inclusion criteria one and two.
Out of these 62 patients retrieved from our archive, 11
patients with missing information regarding long-term
outcome (patients lost to follow-up, not meeting inclu-
sion criteria three) or with missing radiographs provid-
ing mid-term outcome information (n = 5) were
excluded.
Surgery
All procedures were performed under general anaesthe-
sia. Surgical procedures were the following: a) simple
curettage, b) curettage followed by bone grafting with
autograft or allograft, c) aspiration and injection with
methylprednisolone, d) decompression by hollow screws.
One patient was initially treated conservatively. Due to
persistence of symptoms, he was later treated with cur-
ettage followed by bone grafting.
Curettage
Access to the cavity was achieved by applying four to six
drill holes to the bone just over the cystic cavity and
r e m o v i n gab o n yw i n d o ww i t ht h eh e l po fac h i s e l .T h e
whole of the cavity was then addressed with a bone cur-
ette and the cyst membrane was removed under x-ray
control, assuring that curettage was clearly performed
beyond the radiographic circumference of the cyst. The
bone window was not put back into place.
Curettage and bone graft
The technique of curettage was performed as mentioned
above. Bone grafting was either autologous (iliac crest)
or allogenic (acellular bone provided from the bone
bank in our institution).
Steroid injection
Steroid injection was performed in a modified technique
first described by Scaglietti et al. in 1979 [34]. A single
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ray control. A needle was then introduced. Emptying of
cyst fluid was achieved by aspiration. An individual
volume of methylprednisolone was then injected into
the cavity, with the final dose adapted to the size of the
cyst (average dose of 90.0 mg, SD = 68.4 mg, ranging
from 10 mg to 250 mg), filling up the cavity until some
fluid escaped from the bone.
Decompression by cannulated screws
Decompression was achieved by applying up to four
cannulated screws reaching the cystic cavity. The screws
were inserted over x-ray controlled k-wires.
Postoperative treatment and radiological control
Postoperative treatment varied upon localisation of the
cysts, age of the patient, presence of pathologic fracture
etc. and ranged from simple dressings and splints to
plaster cast therapy in the more severe cases.
Radiographs were taken 1, 3, 6 and 12 months after
surgery. Depending on success or recurrence, radiologi-
cal evaluation was then individually modified.
Radiographic analysis
All radiographs taken in the course of treatment were
evaluated by two blinded investigators according to the
following parameters: length (L), width (Q), and depth
(T, taken from a second projection) (Figure 1). By multi-
plication of these 3 parameters, a fourth parameter was
obtained (V, being a dimensionless approximate
“volume” parameter). To rule out errors caused by dif-
ferent x-ray magnifications, scaling of these parameters
was achieved by relating all parameters to a quotient
taken from the distance of the cyst to the adjacent
growth plate to the width of this growth plate (EF, Fig-
ure 1). Growth and recurrence were analysed by com-
paring these parameters in the course of treatment.
Activity of the cyst was classified into latent and active
according to Jaffe and Lichtenstein [6]. Active cysts were
considered having a distance to the adjacent growth
plate (d, Figure 1) of less than 10 mm, while latent cysts
were considered having a distance of 10 mm or more.
Postoperative radiographs were classified for successful
treatment using a modification of a classification system
first described by Neer [35] and modified by Chang et
al. [36] (Table 1).
Long-term clinical outcome
In the year 2007, with a minimum follow-up of 10 years,
all patients were polled with a questionnaire for pre-
sence or absence of pain, activity, contentment with
treatment outcome (grades 1 to 6) and necessity of
further treatment outside our institution for UBC.
Statistical analysis
Analysis was conducted using SPSS software (version 15,
SPSS Inc., Chicago, IL, USA). For the analysis of dichot-
omous variables between two groups, a chi-square cross
tab test was performed. Values of p < 0.05 were consid-
ered significant.
Figure 1 Radiographic evaluation of UBC morphology.T h e
radiographs were evaluated according to the following parameters:
length (L), width (Q), width of the growth plate (EF), distance from
the adjacent growth plate (d) and distance from the growth plate
to the joint (GH).
Table 1 Modified Neer classification system for postoperative radiological evaluation of unicameral bone cysts
according to Chang et al
Healed Cyst filled by formation of new bone with or without small static, radiolucent area(s) less than 1 cm in size.
Healing with defect Static, radiolucent area(s) less than 50% of the diameter of the bone with enough cortical thickness to prevent fracture.
Persistent cyst Radiolucent areas greater than 50% of diameter of the bone and with a thin cortical rim. No increase in cyst size.
Recurrent cyst Cyst reappeared in a previously obliterated area
or a residual radiolucent area has increased in size.
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Forty-six patients (17 female, 29 male) with a mean age
of 10.0 ± 4.8 years were included. An overview of
patient’s features and response to treatment is given in
Table 2. In 42 of 46 cases, diagnosis was confirmed by
positive histology in the course of first surgery. In the
four remaining cases, no material for histopathological
analysis had been obtained during primary therapy for
technical reasons. Diagnosis was in these cases at first
confirmed by typical radiographic morphology and
operative observation. In these four cases, histopatholo-
gical diagnosis was later confirmed in the course of revi-
sion surgery.
The cysts were mainly located in long bones (40/46),
predominantly in the femur (n = 17) and the humerus
(n = 16). The other localisations among long bones
were the tibia (n = 3), fibula (n = 3) and radius (n = 1).
In the long bones, cysts were predominantly located in
the proximal parts (n = 32). Four cysts were located in
the calcaneus, one in the metacarpal and one in the
ilium. Twenty-nine of the 46 cysts were located on the
left side of the body, while only 17 were located on the
right side.
Thirty-eight patients (83%) presented to our institu-
t i o nb e c a u s eo fp a i n .O u to ft h et o t a ln u m b e ro f4 6
patients, 21 were found to have a pathological fracture
(46%). 17 patients experienced pain without fracture. In
the remaining 8 patients presenting to our institution,
UBC had been discovered incidentally. These patients
had not encountered any symptoms in the past. In 23
cases, medical consultation took place within the first
weeks of the onset of pain. Out of these, 15 pathological
fractures could be detected. Medical consultation was
significantly faster in case of a pathological fracture (p <
0.01). In the remaining 23 patients, mean duration until
medical consultation was 16.3 ± 20.2 weeks.
Pathological fractures were significantly more often
detected in the humerus than in the femur (13/17 vs. 5/
16, p = 0.009) (Figure 2). No significant difference was
observed between pathological fractures in male and
female patients (15/29 vs. 6/17, p = 0.28).
Upon evaluation of the initial x-rays taken before the
beginning of the treatment, 21 cysts were classified as
active (distance to the adjacent growth plate less than
10 mm), while 19 cysts were classified as inactive (or
latent). In the remaining six cases (4 female patients, 2
male patients), due to the localization of the cysts, clas-
sification into active or inactive was not feasible. Active
cysts were not significantly more often found in male
than in female patients (16 out of 27 classified cysts vs.
5 out of 13 classified cysts, p = 0.217, Figure 3).
All patients received at least one surgical treatment in
our institution. One patient was initially treated conser-
vatively for a pathological fracture of the proximal
humerus. Fracture consolidation was attained, but the
patient remained symptomatic with pain. Radiographs
showed a growing cyst (Figure 4a and 4b), therefore,
curettage and bone grafting were performed. In total, as
a primary surgical therapy, curettage and bone grafting
were performed in 35 cases. 9 patients were treated with
autologous bone graft from the iliac crest, in the 26
remaining cases, bone grafting was performed with acel-
lular bone derived from our bone bank.
In four cases, curettage was performed without bone
grafting. Another three patients were treated by corti-
coid injections, while in four patients, cannulated screws
were applied.
Recurrent fractures were observed in nine cases (three
femur, six humerus), with no significant difference
among the different procedures.
Overall recurrence rate after primary surgical therapy
was 39% (18/46) for all surgical procedures, recurrence
being defined as requiring further surgical treatment. In
eight of these patients (17.4%), a second recurrence was
observed, while in two cases (4.3%), three repetitive sur-
geries had to be carried out. These cases were treated
by curettage and bone grafting.
Recurrence rate for curettage and bone grafting was
37% (13/35). There was no significant difference in out-
come between the group treated with autologous (n =
26) bone graft and allograft (n = 9). The recurrence rate
for curettage alone was 0% (4/4 cysts considered
“healed” in follow-up). These cysts had been located in
the distal tibia, the distal fibula, the distal humerus and
the proximal femur. Two out of 3 cysts showed recur-
rence after corticoid instillation. Two out of 4 cysts
showed recurrence after decompression with cannulated
screws.
Independent from treatment, active cysts showed a
significantly higher recurrence rate than latent ones (13/
21 vs. 5/19, p = 0.025, odds ratio 2.5, Figure 5). In
patients presenting with pathologic fractures, probability
of recurrence was significantly elevated (p = 0.024, odds
ratio 4.66). Patients who were younger than 10 years
when diagnosed with UBC had a significantly elevated
probability of recurrence (p = 0.004, odds ratio 6.52).
Interestingly, when recurrence occurred later than 30
weeks after the last surgery, prognosis was significantly
better compared to recurrence within 30 weeks after
surgery: a second recurrence was only observed in one
o u to f1 4p a t i e n t so ft h ef o r m e rc o m p a r e dt o9o u to f
12 in the latter (p < 0.01, odds ratio 40). Recurrence
was higher in male patients (14/29, 48%) than in female
patients (4/17, 28%), but this was not statistically signifi-
cant (p = 0.09).
To evaluate radiographic mid-term results, the last
radiographs taken in the course of treatment were ana-
lysed. After a mean clinical and radiological follow-up of
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Patient Sex Age Cyst localization Side Fracture Initial treatment Bone graft Recurrence
AS f 8 proximal fibula Left no Curettage + bone graft allogeneic no
BH m 5 distal humerus Left yes conservative none yes
BJ m 11 proximal femur Left no curettage none no
BK f 6 distal humerus Left yes Curettage + bone graft allogeneic yes
BL f 13 distal humerus Left no Curettage + bone graft allogeneic no
BM f 4 proximal femur Left yes Curettage + bone graft allogeneic no
BS f 5 proximal femur Left no Curettage + bone graft allogeneic no
DA m 4 distal fibula Left no Curettage + bone graft allogeneic yes
EB m 7 distal fibula Left yes Curettage + bone graft allogeneic yes
ES f 11 calcaneus Right no curettage none no
ET m 14 proximal femur Left no Curettage + bone graft allogeneic yes
ET m 9 calcaneus Right no Curettage + bone graft allogeneic no
GA m 9 distal humerus Right no Curettage + bone graft allogeneic yes
GE f 19 medial humerus Right no Curettage + bone graft autologous no
GM m 6 distal humerus Right yes Curettage + bone graft allogeneic yes
GS f 2 proximal femur Left no Curettage + bone graft allogeneic yes
HE f 14 distal tibia Right yes Curettage + bone graft autologous no
HF m 11 proximal femur Right no Curettage + bone graft allogeneic no
HH f 22 proximal femur Left no Curettage + bone graft autologous no
HM m 8 distal humerus Left yes Curettage + bone graft allogeneic no
HSa m 13 distal humerus Right yes Curettage + bone graft allogeneic no
HSb m 13 distal humerus Right yes Curettage + bone graft autologous yes
JA m 14 distal humerus Left yes curettage none no
JW m 12 proximal femur Left yes Curettage + bone graft autologous no
KA m 7 distal humerus Left yes Curettage + bone graft allogeneic yes
KC m 10 proximal femur Right no Curettage + bone graft allogeneic no
KD f 12 proximal fibula Left yes cortisone instillation none no
KF m 10 distal humerus Right yes cortisone instillation none yes
KJ m 23 proximal femur Left no Curettage + bone graft allogeneic no
KO m 6 proximal femur Right no Curettage + bone graft allogeneic no
LF m 5 distal fibula Left yes Curettage + bone graft autologous yes
LM f 6 distal fibula Left yes cortisone instillation none yes
MC m 10 proximal tibia Left no Curettage + bone graft allogeneic no
NU f 19 ilium Left no Curettage + bone graft allogeneic no
RC f 13 calcaneus Left no Curettage + bone graft autologous no
RMa m 8 proximal femur Right yes Curettage + bone graft allogeneic no
RMb m 9 distal humerus Left no Curettage + bone graft allogeneic yes
SC m 11 metacarpal Right no Curettage + bone graft allogeneic yes
SS m 10 distal humerus Left no screws none no
VF f 13 proximal radius Right no Curettage + bone graft allogeneic no
VK m 16 calcaneus Left no Curettage + bone graft autologous no
VT m 12 proximal femur Left no Curettage + bone graft autologous yes
WC f 4 distal humerus Right no screws none yes
WM m 6 distal humerus Right yes screws none yes
WS m 10 distal humerus Left yes screws none no
ZM f 2 distal tibia Left no curettage none no
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“healed” according to the classification system men-
tioned above. Three patients showed “persistent cysts”,
while three patients showed “recurrent cysts”,b u t
declined further therapy. Three cases are demonstrated
i nF i g u r e s6 ,7 ,8 .F i g u r e9o u tlines overall and specific
treatment outcome. No significant difference was
observed between the different therapies.
After a mean follow-up of 15.5 ± 6.2 years, all 46
patients were polled on long-term clinical outcome.
Forty patients reported to have no pain and no func-
tional limitations, five reported mild and casual pain,
and one patient reported a mild limitation of range of
motion in the shoulder joint without pain. In these lat-
ter six patients, medical consultations had not been able
t or e v e a lt h ea g e n to fp a i n ,n o t a b l y ,n or e c u r r e n c eo f
UBC had been detected. The six symptomatic patients
were all male and had been treated with curettage and
bone grafting. The localizations of the cysts in these
patients were: proximal humerus (n = 2), proximal
femur (n = 2), distal tibia (n = 1) and calcaneus (n = 1).
In five of six cases, only one surgery had been per-
formed without recurrence after first-line treatment,
while in only one case revision surgery had been per-
formed twice. Overall satisfaction with therapy was high,
with the grades for contentment with therapy being dis-
tributed as follows: 14/46 (30%) grade 1, 29/46 (63%)
grade 2, and 3/46 (7%) grade 3.
Discussion
Since the first description of unicameral bone cysts by
Virchow in 1876, different treatments have been pro-
posed and evaluated. However, up to this day, there is
no agreement on a successful standard therapy. A wide
range of methods is available, from rather minimally
invasive techniques such as aspiration and injection of
steroids or bone marrow to more radical open techni-
ques. All of these methods share a considerable percen-
tage of recurrence. Our findings suggest that overall
long-term results of surgical therapy are satisfactory.
This perception is shared by the few studies providing
long-term results of UBC treatment [37,38]. These
results demonstrate that regardless of the four treatment
strategies used in this study, therapeutic success will
likely arise. However, as our data demonstrate, a consid-
erable rate of recurrence can be expected during first,
second and even third-line therapy. It is therefore
important to scientifically evaluate whether certain
methods present a significant reduction in recurrence in
the future.
Limitations: Our study population is comparable to
other studies regarding age, gender ratio and incidence
of pathologic fractures [18,39-41]. Like all retrospective
studies, the study has certain limitations, e.g. regarding
patient selection. However, unlike in most other retro-
spective studies, we were able to include a total of 46
out of 62 patients in which both radiographic material
and long-term clinical information was available for ana-
lysis and was systematically revised. The outcome was
objectified by quantitative radiological measurements.
Histopathological diagnosis was obtained in all patients;
therefore, although presenting a rather average amount
of cases, results are not falsified by inclusion of tumours
of other origin. Due to the small numbers of patients
Figure 2 Frequency of pathologic fractures related to
localization of UBC. Fractures were significantly more often
observed in patients with UBC located in the humerus (p = 0.009).
Figure 3 Frequency of active cysts related to male and female
sex.
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tage without bone grafting, a comparison of the different
therapies applied is not feasible. However, the results of
these therapies were included to be compared to other
studies and because many of the more recent studies on
UBC therapy have provided information on a juxtaposi-
tion of these techniques.
In our study, pathological fractures were significantly
more often located in the humerus than in the femur,
comparable to previous studies [26]. It is believed that
due to the absence of a significant weight load, which
usually leads to significant pain, UBC in the humerus
remain undetected longer than in the femur. Thus, UBC
in the humerus often grow until they reveal themselves
through a pathological fracture usually arising in the
context of a minimal trauma.
We were able to detect significant risk factors for
recurrence already depicted in important previous stu-
dies, such as male sex, young age [31,36] and active
cysts [15,18]. To our knowledge, this is the first study to
report that recurrence after more than 30 weeks past
surgery is correlated with lower re-recurrence rates in
revision surgery. It can only be postulated that less
expansive properties of these “late-onset” recurrent cysts
may be responsible for this effect.
Almost all of the patients in our collective were treated
with curettage and bone graft, either for primary therapy,
or for revision surgery. This procedure showed a recur-
rence rate of 37% (13/35). Previous studies have shown
recurrence rates of 20 to 40% for this technique [18,31,35].
Figure 4 (a) Pathological fracture of the proximal humerus in a male patient (5 y) initially treated conservatively.( b) 5 months later, the
fracture is consolidated. However, the cyst shows significant growth progression.
Figure 5 Frequency of recurrence related to preoperative
classification into active and latent. Recurrence was significantly
higher in patients with UBC classified as active (p = 0.025).
Hagmann et al. BMC Musculoskeletal Disorders 2011, 12:281
http://www.biomedcentral.com/1471-2474/12/281
Page 7 of 12Hunt et al. experienced healing rates of 75% for the first
procedure and 95% for the second procedure of percutea-
neous drainage, curettage and a combination of auto- and
allograft [42]. In this study, there was no significant
difference in recurrence between the groups treated with
autologous graft or allograft. Use of autologous and allo-
genic bone graft has been discussed most controversially.
Obtaining autograft from the tibia or the iliac crest is likely
Figure 6 (a) 12-year-old male patient treated by curettage and bone grafting for UBC of the right proximal femur.( b) 7 month later,
UBC was considered “healed” with complete consolidation of the graft.
Figure 7 (a) 6-year-old female patient initially treated by injection of methylprednisolone. The picture shows the situation before the first
injection. (b) 7 months later (3 month after revision curettage and bone grafting for pathological fracture of the distal femur in the course of
corticoid therapy). (c) 16 years after the initial radiograph. No aspect of UBC is remaining.
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Page 8 of 12Figure 8 11-year-old male patient initially treated by curettage and homologous bone grafting.( a) Before treatment. (b) 2 months later
after surgery. (c) 8 years after surgery. Some aspect of UBC is remaining, while the patient is asymptomatic.
Figure 9 Midterm outcome after 52 months for the different surgical therapies.
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Page 9 of 12to lead to significant morbidity. In some institutions, this
explant morbidity has induced certain reluctance towards
autografts, particularly in children. On the other hand,
allografts are estimated to exhibit reduced osteogenic
properties when compared to autografts [35]. Some
authors therefore propagate superiority of autologous
bone [43,44]. Also, even in acellular bone, the potential
risk of infection allocated with allograft transplantation
has generated some restraints to its use. In our opinion,
when discussing autografts and allografts, it is therefore
important to consider that in our study, bone healing
could be effectively attained with allografts.
Because of the disadvantages of both allo-and auto-
grafts, bone substitutes have become widely used in
adult orthopedics and traumatology treatment in the
last decades [45,46]. Yet therei sl i t t l ee v i d e n c eo ft h e i r
efficacy and studies comparing bone substitutes to bone
graft or spontaneous bone healing are missing. A recent
study reported healing rates of 66% for curettage and
calcium sulfate bone substitute grafting and 91% for a
combination of curettage, ethanol cauterization, cyst
membrane disruption and combined calcium sulfate
bone substitute grafting [47]. A healing rate of over 90%
in a minimally-invasive approach of curettage and cal-
cium sulfate pellet grafting has also been reported by
Dormans et al. [28]. However, these are the first studies
to report on bone substitutes in UBC therapy and
further studies are required to confirm the promising
results. An important question is whether the use of any
of the materials specified above is essential for bone
healing in these lesions. Hirn et al. reported good results
of curettage without bone grafting in benign tumours of
the distal femur and the proximal tibia, with a recur-
rence rate of 11% in mostly giant cell tumours, chondro-
blastoma and aneurysmal bone cysts [48]. It is unclear if
these results can be extrapolated to unicameral bone
cysts, but the study can be regarded as evidence for the
high self-healing potential of long bones. In our study,
only four patients were treated with curettage without
bone graft transplantation. A recent study reported heal-
ing rates of 70% percent for this technique [49], which
applies to our findings concerning curettage combined
with bone grafting. In our study however, no recurrence
was observed in the group who had been treated with
curettage alone. This may be due to a more aggressive
curettage than in the cases treated with a combine bone
grafting. Aggressive debridement has been shown to sig-
nificantly reduce the percentage of recurrent cysts in
previous studies [50,51]. Localization of the cysts did
n o ts e e mt oa c c o u n tf o rt h er e s u l t s ,a st h ec y s t sw e r e
localized in four different bones. However, due to the
small number of patients treated with curettage alone in
our collective, the comparison to those treated with
bone graft is not legitimate.
In the 1980s and early 1990s, only a small number of
patients were treated by corticoid injections in our insti-
tution. Recurrence in our study was 66% for this treat-
ment. However, corticoid injections have been reported
t os h o wg o o dr e s u l t sb yn u m e r o u sg r o u p s[ 3 6 , 5 2 ] .S c a -
glietti, being the pioneer of this treatment, reported
healing rates of 70% to 90% [30,34]. More recent studies
have reported healing rates from 33% to 41% [47,49].
However, apart from the minimal trauma resulting from
the injection technique, considerable recurrence rates
and the need for multiple injections have been reported
[31,53]. A study comparing injections of bone marrow
in 14 and cortisone in 65 patients reported a need for
multiple injections in 57% and 49%, respectively [36].
Postoperative fracture rates also vary importantly among
the studies, ranging from 2% to over 30% [30,34,54].
These disadvantages are clearly modifying the benefits
of this minimal invasive technique.
In the recent past, cannulated screws have established
themselves among the therapies for UBC, promising
continuous decompression of the cystic cavity [21,22].
Healing rates between 67 and 92% have been reported
[27,47,55]. However, other studies suggest that treat-
ment failures and a significant amount of persistent
defects after healing are often observed [56]. A combina-
tion of cannulated screws with curettage and calcium
sulfate grafting was reported to show recurrence rates
of less than 10% [47]. In our study, recurrence rate for
decompression with cannulated screws was 50%. Again,
due to the small number of patients treated with corti-
coids or cannulated screws in this study, no comparison
can be made with the other surgical therapies in this
study. However, we chose to include these cases to pro-
vide information on long-term clinical results for all
approaches. The coexistence of different surgical
approaches is experienced both in clinical practice and
the literature. In different institutions, the frequency of
the therapies applied can significantly vary, according to
personal experience and beliefs. Interestingly, out of the
six patients with abiding symptoms in 2007, six had
received curettage and bone grafting. Among these, five
had been successfully treated after only one surgical
intervention. This suggests that short- and mid-term
success is not to be equalized with a guarantee on
patients free of complaints in a long-term consideration.
Conclusions
We were able to provide long-term clinical outcome for
surgical treatment of unicameral bone cysts. Our results
suggest satisfactory overall long-term outcome, but
short-and mid-term observation showed a considerable
rate of recurrence for all strategies applied. To our
knowledge, this is the first study to report that patients
experiencing recurrence later than 30 months after
Hagmann et al. BMC Musculoskeletal Disorders 2011, 12:281
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Page 10 of 12surgery have a better prognosis regarding revision sur-
gery. Considering the almost assured long-term success
o fU B Ct h e r a p y ,i n v a s i v es t r a t e g i e sh a v et ob ec a r r i e d
out as cautious as possible.
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